Skip to main content
Clinical Trials/CTRI/2022/02/040567
CTRI/2022/02/040567
Not yet recruiting
Phase 2

Scientific Validation on therapeutic effectiveness of siddha formulation Dhiratchathi chooranam mathirai in the management of Paandu (Anaemia) â?? A Pilot Study

ational institute ofsiddha0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: D539- Nutritional anemia, unspecified
Sponsor
ational institute ofsiddha
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ational institute ofsiddha

Eligibility Criteria

Inclusion Criteria

  • Sex both sex and transgender
  • Hb level less than normal range
  • For male 9\-11gms/d1 (normal 13 gms/d1] For female 8\-10gms /dl (normal 12 gms/d1]
  • Patient willing to undergo blood investigation.
  • Patients who are willing to participate in study and signing in informed consent form.

Exclusion Criteria

  • Presence of any associated severe systemic illness (e.g. Cancer, AIDS)
  • Known C/O Chronic Kidney Disease
  • Known C/O Endocrine disorder (Thyroid abnormality, Diabetes mellitus)
  • Known C/O Severe Cardiac Disease (or) IHD
  • Known C/O Inherited defects (Sickle Cell Anaemia, Thalassemia, Aplastic Anaemia)
  • Patients not willing to give blood sample.
  • Pregnant and lactating mother.

Outcomes

Primary Outcomes

Not specified

Similar Trials